Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

This document (A60281) is a response to comments on the Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) LCD L40050. It records the comment period (2/7/25–3/23/25), the notice period beginning 9/11/25, and the LCD effective date of 10/26/25; the provided text contains no coverage criteria, limitations, documentation requirements, or frequency limits to extract.